Families USA Statement for the Record for Energy and Commerce’s Health Subcommittee Hearing on Lowering Health Care Costs on Prescription Drugs

Families USA submitted a statement on the Energy and Commerce Health Subcommittee outlining how big drug companies and Pharmacy Benefit Managers (PBM) are driving up the cost of prescription drugs.

Our statement recommends Congress focus on the following reforms to crack down on corporate greed that is driving these higher costs:

• Reverse restrictions on CMS’ ability to negotiate for lower costs on certain blockbuster drugs
• Extend the Medicare inflation rebate to the commercial market
• Expand the number of drugs subject to negotiation and allow commercial health insurance to voluntarily adopted the negotiated rate
• End patent abuses

Families USA appreciates the Subcommittee’s focus on this critical issue and looks forward to working with all of its members to improve affordable and accessible prescription drugs.